{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:13:45Z","timestamp":1789517625970,"version":"build-2803163510"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03623-0","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T13:02:03Z","timestamp":1703163723000},"page":"548-558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cardiac disease in Cushing\u2019s syndrome. Emphasis on the role of cardiovascular magnetic resonance imaging"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2918-7461","authenticated-orcid":false,"given":"Melpomeni","family":"Moustaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Markousis-Mavrogenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andromachi","family":"Vryonidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavroula A.","family":"Paschou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Mavrogeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"key":"3623_CR1","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"L.K. Nieman, B.M.K. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, H. Edwards, The diagnosis of Cushing\u2019s syndrome: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93, 1526\u20131540 (2008). https:\/\/doi.org\/10.1210\/jc.2008-0125","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3623_CR2","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s40265-014-0282-9","volume":"74","author":"L Fardet","year":"2014","unstructured":"L. Fardet, B. F\u00e8ve, Systemic glucocorticoid therapy: A review of its metabolic and cardiovascular adverse events. Drugs 74, 1731\u20131745 (2014). https:\/\/doi.org\/10.1007\/s40265-014-0282-9","journal-title":"Drugs"},{"key":"3623_CR3","doi-asserted-by":"publisher","unstructured":"O.A. Hakami, S. Ahmed, N. Karavitaki, Epidemiology and mortality of Cushing\u2019s syndrome. Best Pract.Res. Clin. Endocrinol. Metabol. 35, (2021). https:\/\/doi.org\/10.1016\/j.beem.2021.101521","DOI":"10.1016\/j.beem.2021.101521"},{"key":"3623_CR4","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","volume":"4","author":"R Pivonello","year":"2016","unstructured":"R. Pivonello, A.M. Isidori, M.C. De Martino, J. Newell-Price, B.M.K. Biller, A. Colao, Complications of Cushing\u2019s syndrome: State of the art. Lancet Diabetes Endocrinol. 4, 611\u2013629 (2016). https:\/\/doi.org\/10.1016\/S2213-8587(16)00086-3","journal-title":"Lancet Diabetes Endocrinol."},{"key":"3623_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/HJH.0000000000000415","volume":"33","author":"AM Isidori","year":"2015","unstructured":"A.M. Isidori, C. Graziadio, R.M. Paragliola, A. Cozzolino, A.G. Ambrogio, A. Colao, S.M. Corsello, R. Pivonello, The hypertension of Cushing\u2019s syndrome: Controversies in the pathophysiology and focus on cardiovascular complications. J. Hypertens. 33, 44\u201360 (2015). https:\/\/doi.org\/10.1097\/HJH.0000000000000415","journal-title":"J. Hypertens."},{"key":"3623_CR6","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.tips.2013.07.003","volume":"34","author":"M Kadmiel","year":"2013","unstructured":"M. Kadmiel, J.A. Cidlowski, Glucocorticoid receptor signaling in health and disease. Trends Pharm. Sci. 34, 518\u2013530 (2013). https:\/\/doi.org\/10.1016\/j.tips.2013.07.003","journal-title":"Trends Pharm. Sci."},{"key":"3623_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2265.2010.03829.x","volume":"73","author":"EB Geer","year":"2010","unstructured":"E.B. Geer, W. Shen, D. Gallagher, M. Punyanitya, H.C. Looker, K.D. Post, P.U. Freda, MRI assessment of lean and adipose tissue distribution in female patients with Cushing\u2019s disease. Clin. Endocrinol. (Oxf.) 73, 469\u2013475 (2010). https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03829.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"3623_CR8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1530\/eje.0.1490561","volume":"149","author":"AG Rockall","year":"2003","unstructured":"A.G. Rockall, S.A. Sohaib, D. Evans, G. Kaltsas, A.M. Isidori, J.P. Monson, G.M. Besser, A.B. Grossman, R.H. Reznek, Computed tomography assessment of fat distribution in male and female patients with Cushing\u2019s syndrome. Eur. J. Endocrinol. 149, 561\u2013567 (2003)","journal-title":"Eur. J. Endocrinol."},{"key":"3623_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1210\/er.2016-1105","volume":"38","author":"C Scaroni","year":"2017","unstructured":"C. Scaroni, M. Zilio, M. Foti, M. Boscaro, Glucose metabolism abnormalities in cushing syndrome: from molecular basis to clinical management. Endocr. Rev. 38, 189\u2013219 (2017). https:\/\/doi.org\/10.1210\/er.2016-1105","journal-title":"Endocr. Rev."},{"key":"3623_CR10","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"M. Fleseriu, R. Auchus, I. Bancos, A. Ben-Shlomo, J. Bertherat, N.R. Biermasz, C.L. Boguszewski, M.D. Bronstein, M. Buchfelder, J.D. Carmichael, F.F. Casanueva, F. Castinetti, P. Chanson, J. Findling, M. Gadelha, E.B. Geer, A. Giustina, A. Grossman, M. Gurnell, K. Ho, A.G. Ioachimescu, U.B. Kaiser, N. Karavitaki, L. Katznelson, D.F. Kelly, A. Lacroix, A. McCormack, S. Melmed, M. Molitch, P. Mortini, J. Newell-Price, L. Nieman, A.M. Pereira, S. Petersenn, R. Pivonello, H. Raff, M. Reincke, R. Salvatori, C. Scaroni, I. Shimon, C.A. Stratakis, B. Swearingen, A. Tabarin, Y. Takahashi, M. Theodoropoulou, S. Tsagarakis, E. Valassi, E.V. Varlamov, G. Vila, J. Wass, S.M. Webb, M.C. Zatelli, B.M.K. Biller, Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol. 9, 847\u2013875 (2021). https:\/\/doi.org\/10.1016\/S2213-8587(21)00235-7","journal-title":"Lancet Diabetes Endocrinol."},{"key":"3623_CR11","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/cphy.c130044","volume":"4","author":"E Gomez-Sanchez","year":"2014","unstructured":"E. Gomez-Sanchez, C.E. Gomez-Sanchez, The multifaceted mineralocorticoid receptor. Compr. Physiol. 4, 965\u2013994 (2014). https:\/\/doi.org\/10.1002\/cphy.c130044","journal-title":"Compr. Physiol."},{"key":"3623_CR12","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1007\/s11102-022-01258-4","volume":"25","author":"A Coulden","year":"2022","unstructured":"A. Coulden, R. Hamblin, J. Wass, N. Karavitaki, Cardiovascular health and mortality in Cushing\u2019s disease. Pituitary 25, 750\u2013753 (2022). https:\/\/doi.org\/10.1007\/s11102-022-01258-4","journal-title":"Pituitary"},{"key":"3623_CR13","doi-asserted-by":"publisher","first-page":"R207","DOI":"10.1530\/EJE-20-1309","volume":"184","author":"EV Varlamov","year":"2021","unstructured":"E.V. Varlamov, F. Langlois, G. Vila, M. Fleseriu, Cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing\u2019s syndrome: A practical approach. Eur. J. Endocrinol. 184, R207\u2013R224 (2021). https:\/\/doi.org\/10.1530\/EJE-20-1309","journal-title":"Eur. J. Endocrinol."},{"key":"3623_CR14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ecl.2019.08.005","volume":"48","author":"LK Nieman","year":"2019","unstructured":"L.K. Nieman, Hypertension and cardiovascular mortality in patients with cushing syndrome. Endocrinol. Metab. Clin. North Am. 48, 717\u2013725 (2019). https:\/\/doi.org\/10.1016\/j.ecl.2019.08.005","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"3623_CR15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S2213-8587(16)30005-5","volume":"4","author":"RN Clayton","year":"2016","unstructured":"R.N. Clayton, P.W. Jones, R.C. Reulen, P.M. Stewart, Z.K. Hassan-Smith, G. Ntali, N. Karavitaki, O.M. Dekkers, A.M. Pereira, M. Bolland, I. Holdaway, J. Lindholm, Mortality in patients with Cushing\u2019s disease more than 10 years after remission: A multicentre, multinational, retrospective cohort study. Lancet Diabetes Endocrinol. 4, 569\u2013576 (2016). https:\/\/doi.org\/10.1016\/S2213-8587(16)30005-5","journal-title":"Lancet Diabetes Endocrinol."},{"key":"3623_CR16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1530\/EJE-13-0569","volume":"169","author":"G Ntali","year":"2013","unstructured":"G. Ntali, A. Asimakopoulou, T. Siamatras, J. Komninos, D. Vassiliadi, M. Tzanela, S. Tsagarakis, A.B. Grossman, J.A.H. Wass, N. Karavitaki, Mortality in Cushing\u2019s syndrome: Systematic analysis of a large series with prolonged follow-up. Eur. J. Endocrinol. 169, 715\u2013723 (2013). https:\/\/doi.org\/10.1530\/EJE-13-0569","journal-title":"Eur. J. Endocrinol."},{"key":"3623_CR17","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1210\/jc.2018-02524","volume":"104","author":"O Ragnarsson","year":"2019","unstructured":"O. Ragnarsson, D.S. Olsson, E. Papakokkinou, D. Chantzichristos, P. Dahlqvist, E. Segerstedt, T. Olsson, M. Petersson, K. Berinder, S. Bensing, C. Hoybye, B. Eden-Engstrom, P. Burman, L. Bonelli, C. Follin, D. Petranek, E.M. Erfurth, J. Wahlberg, B. Ekman, A.K. Akerman, E. Schwarcz, I.L. Bryngelsson, G. Johannsson, Overall and disease-specific mortality in patients with cushing disease: A Swedish nationwide study. J. Clin. Endocrinol. Metab. 104, 2375\u20132384 (2019). https:\/\/doi.org\/10.1210\/jc.2018-02524","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3623_CR18","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1210\/jc.2010-1942","volume":"96","author":"RN Clayton","year":"2011","unstructured":"R.N. Clayton, D. Raskauskiene, R.C. Reulen, P.W. Jones, Mortality and morbidity in Cushing\u2019s disease over 50 Years in Stoke-on-Trent, UK: Audit and meta-analysis of literature. J. Clin. Endocrinol. Metab. 96, 632\u2013642 (2011). https:\/\/doi.org\/10.1210\/jc.2010-1942","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3623_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jendso\/bvac045","volume":"6","author":"D Bengtsson","year":"2022","unstructured":"D. Bengtsson, O. Ragnarsson, K. Berinder, P. Dahlqvist, B.E. Engstr\u00f6m, B. Ekman, C. H\u00f6ybye, J. J\u00e4r\u00e5s, S. Valdemarsson, P. Burman, J. Wahlberg, Increased Mortality Persists after Treatment of Cushing\u2019s Disease: A Matched Nationwide Cohort Study. J. Endocr. Soc. 6, 1\u201310 (2022). https:\/\/doi.org\/10.1210\/jendso\/bvac045","journal-title":"J. Endocr. Soc."},{"key":"3623_CR20","doi-asserted-by":"publisher","unstructured":"L. Fardet, I. Petersen, I. Nazareth, Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing\u2019s syndrome: Cohort study. BMJ (Online). 345, (2012). https:\/\/doi.org\/10.1136\/bmj.e4928","DOI":"10.1136\/bmj.e4928"},{"key":"3623_CR21","doi-asserted-by":"publisher","unstructured":"R.N. Clayton, Cardiovascular complications of Cushing\u2019s syndrome: Impact on morbidity and mortality. J Neuroendocrinol. 34, (2022). https:\/\/doi.org\/10.1111\/jne.13175","DOI":"10.1111\/jne.13175"},{"key":"3623_CR22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1365-2265.2011.04206.x","volume":"76","author":"PM Toja","year":"2012","unstructured":"P.M. Toja, G. Branzi, F. Ciambellotti, P. Radaelli, M. De Martin, L.M. Lonati, M. Scacchi, G. Parati, F. Cavagnini, F.P. Giraldi, Clinical relevance of cardiac structure and function abnormalities in patients with Cushing\u2019s syndrome before and after cure. Clin. Endocrinol. 76, 332\u2013338 (2012). https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04206.x","journal-title":"Clin. Endocrinol."},{"key":"3623_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1530\/EJE-09-0621","volume":"162","author":"AM Pereira","year":"2010","unstructured":"A.M. Pereira, V. Delgado, J.A. Romijn, J.W.A. Smit, J.J. Bax, R.A. Feelders, Cardiac dysfunction is reversed upon successful treatment of Cushing\u2019s syndrome. Eur. J. Endocrinol. 162, 331\u2013340 (2010). https:\/\/doi.org\/10.1530\/EJE-09-0621","journal-title":"Eur. J. Endocrinol."},{"key":"3623_CR24","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/S0735-1097(03)00493-5","volume":"41","author":"ML Muiesan","year":"2003","unstructured":"M.L. Muiesan, M. Lupia, M. Salvetti, C. Grigoletto, N. Sonino, M. Boscaro, E. Agabiti Rosei, F. Mantero, F. Fallo, Left ventricular structural and functional characteristics in Cushing\u2019s syndrome. J. Am. Coll. Cardiol. 41, 2275\u20132279 (2003). https:\/\/doi.org\/10.1016\/S0735-1097(03)00493-5","journal-title":"J. Am. Coll. Cardiol."},{"key":"3623_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s12020-016-0986-6","volume":"55","author":"E Avenatti","year":"2017","unstructured":"E. Avenatti, A. Rebellato, A. Iannaccone, M. Battocchio, F. Dassie, F. Veglio, A. Milan, F. Fallo, Left ventricular geometry and 24-h blood pressure profile in Cushing\u2019s syndrome. Endocrine 55, 547\u2013554 (2017). https:\/\/doi.org\/10.1007\/s12020-016-0986-6","journal-title":"Endocrine"},{"key":"3623_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1530\/EJE-11-0601","volume":"166","author":"KH Yiu","year":"2012","unstructured":"K.H. Yiu, N.A. Marsan, V. Delgado, N.R. Biermasz, E.R. Holman, J.W.A. Smit, R.A. Feelders, J.J. Bax, A.M. Pereira, Increased myocardial fibrosis and left ventricular dysfunction in Cushing\u2019s syndrome. Eur. J. Endocrinol. 166, 27\u201334 (2012). https:\/\/doi.org\/10.1530\/EJE-11-0601","journal-title":"Eur. J. Endocrinol."},{"key":"3623_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/jmri.25374","volume":"45","author":"C Roux","year":"2017","unstructured":"C. Roux, N. Kachenoura, Z. Raissuni, E. Mousseaux, J. Young, M.J. Graves, C. Jublanc, P. Cluzel, P. Chanson, P. Kamenick\u00fd, A. Redheuil, Effects of cortisol on the heart: characterization of myocardial involvement in Cushing\u2019s disease by longitudinal cardiac MRI T1 mapping. J. Magn. Reson. Imaging 45, 147\u2013156 (2017). https:\/\/doi.org\/10.1002\/jmri.25374","journal-title":"J. Magn. Reson. Imaging"},{"key":"3623_CR28","doi-asserted-by":"publisher","first-page":"E2144","DOI":"10.1210\/jc.2014-1783","volume":"99","author":"P Kamenick\u00fd","year":"2014","unstructured":"P. Kamenick\u00fd, A. Redheuil, C. Roux, S. Salenave, N. Kachenoura, Z. Raissouni, L. Macron, L. Guignat, C. Jublanc, A. Azarine, S. Brailly, J. Young, E. Mousseaux, P. Chanson, Cardiac structure and function in cushing\u2019s syndrome: A cardiac magnetic resonance imaging study. J. Clin. Endocrinol. Metab. 99, E2144\u2013E2153 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1783","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3623_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1210\/endo.143.1.8583","volume":"143","author":"KE Sheppard","year":"2002","unstructured":"K.E. Sheppard, D.J. Autelitano, 1-Hydroxysteroid Dehydrogenase 1 Transforms 11-Dehydrocorticosterone into Transcriptionally Active Glucocorticoid in Neonatal Rat Heart. Endocrinology 143, 198\u2013204 (2002)","journal-title":"Endocrinology"},{"key":"3623_CR30","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JME-16-0128","volume":"58","author":"GA Gray","year":"2017","unstructured":"G.A. Gray, C.I. White, R.F.P. Castellan, S.J. McSweeney, K.E. Chapman, Getting to the heart of intracellular glucocorticoid regeneration: 11\u03b2-HSD1 in the myocardium. J. Mol. Endocrinol. 58, R1\u2013R13 (2017). https:\/\/doi.org\/10.1530\/JME-16-0128","journal-title":"J. Mol. Endocrinol."},{"key":"3623_CR31","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1161\/01.HYP.0000203772.78696.67","volume":"47","author":"K Nagata","year":"2006","unstructured":"K. Nagata, K. Obata, J. Xu, S. Ichihara, A. Noda, H. Kimata, T. Kato, H. Izawa, T. Murohara, M. Yokota, Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats. Hypertension 47, 656\u2013664 (2006). https:\/\/doi.org\/10.1161\/01.HYP.0000203772.78696.67","journal-title":"Hypertension"},{"key":"3623_CR32","doi-asserted-by":"crossref","unstructured":"A. Frustaci, C. Letizia, R. Verardo, C. Grande, L. Petramala, M.A. Russo, C. Chimenti, Cushing syndrome cardiomyopathy.clinicopathologic impact of cortisol normalization. Circ. Cardiovasc. Imaging. 9, (2016)","DOI":"10.1161\/CIRCIMAGING.116.004569"},{"key":"3623_CR33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jacc.2015.10.040","volume":"67","author":"A Frustaci","year":"2016","unstructured":"A. Frustaci, C. Letizia, R. Verardo, C. Grande, C. Calvieri, M.A. Russo, C. Chimenti, Atrogin-1 pathway activation in cushing syndrome cardiomyopathy. J. Am. Coll. Cardiol. 67, 116\u2013117 (2016). https:\/\/doi.org\/10.1016\/j.jacc.2015.10.040","journal-title":"J. Am. Coll. Cardiol."},{"key":"3623_CR34","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1016\/j.jacc.2018.07.096","volume":"72","author":"F Maurice","year":"2018","unstructured":"F. Maurice, B. Gaborit, C. Vincentelli, I. Abdesselam, M. Bernard, T. Graillon, F. Kober, T. Brue, F. Castinetti, A. Dutour, Cushing syndrome is associated with subclinical LV dysfunction and increased epicardial adipose tissue. J. Am. Coll. Cardiol. 72, 2276\u20132277 (2018). https:\/\/doi.org\/10.1016\/j.jacc.2018.07.096","journal-title":"J. Am. Coll. Cardiol."},{"key":"3623_CR35","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1210\/clinem\/dgab556","volume":"106","author":"P Wolf","year":"2021","unstructured":"P. Wolf, B. Marty, K. Bouazizi, N. Kachenoura, C. Piedvache, A. Blanchard, S. Salenave, M. Prigent, C. Jublanc, C. Ajzenberg, C. Droumaguet, J. Young, A.L. Lecoq, E. Kuhn, H. Agostini, S. Trabado, P.G. Carlier, B. F\u00e8ve, A. Redheuil, P. Chanson, P. Kamenick\u00fd, Epicardial and pericardial adiposity without myocardial steatosis in cushing syndrome. J. Clin. Endocrinol. Metab. 106, 3505\u20133514 (2021). https:\/\/doi.org\/10.1210\/clinem\/dgab556","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3623_CR36","doi-asserted-by":"publisher","unstructured":"F. Tona, M. Boscaro, M. Barbot, L. Maritan, G. Famoso, L.C. Dal, R. Montisci, F. Fallo, S. Iliceto, C. Scaroni, New insights to the potential mechanisms driving coronary flow reserve impairment in Cushing\u2019s syndrome: A pilot noninvasive study by transthoracic Doppler echocardiography. Microvasc. Res. 128, (2020). https:\/\/doi.org\/10.1016\/j.mvr.2019.103940","DOI":"10.1016\/j.mvr.2019.103940"},{"key":"3623_CR37","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/jdi.13653","volume":"13","author":"R Sagara","year":"2022","unstructured":"R. Sagara, T. Inoue, N. Sonoda, C. Yano, M. Motoya, H. Umakoshi, R. Sakamoto, Y. Ogawa, Association between cortisol and left ventricular diastolic dysfunction in patients with diabetes mellitus. J. Diabetes Investig. 13, 344\u2013350 (2022). https:\/\/doi.org\/10.1111\/jdi.13653","journal-title":"J. Diabetes Investig."},{"key":"3623_CR38","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1210\/jc.2012-3582","volume":"98","author":"OM Dekkers","year":"2013","unstructured":"O.M. Dekkers, E. Horv\u00e1th-Puh\u0301o, J.O.L. J\u00f8rgensen, S.C. Cannegieter, V. Ehrenstein, J.P. Vandenbroucke, A.M. Pereira, H.T. Sr\u00f8ensen, Multisystem morbidity and mortality in Cushing\u2019s syndrome: A cohort study. J. Clin. Endocrinol. Metab. 98, 2277\u20132284 (2013). https:\/\/doi.org\/10.1210\/jc.2012-3582","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3623_CR39","doi-asserted-by":"publisher","unstructured":"S. Miao, L. Lu, L. Li, Y. Wang, Z. Lu, H. Zhu, L. Wang, L. Duan, X. Xing, Y. Yao, M. Feng, R. Wang, Clinical characteristics for the improvement of cushing\u2019s syndrome complicated with cardiomyopathy after treatment with a literature review. Front. Cardiovasc. Med. 8, (2021). https:\/\/doi.org\/10.3389\/fcvm.2021.777964","DOI":"10.3389\/fcvm.2021.777964"},{"key":"3623_CR40","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.2169\/internalmedicine.2427-18","volume":"58","author":"M Sakota","year":"2019","unstructured":"M. Sakota, S. Tatebe, K. Sugimura, T. Aoki, S. Yamamoto, H. Sato, N. Kikuchi, R. Konno, Y. Terui, K. Satoh, Y. Tezuka, R. Morimoto, M. Saito, S. Kuniyoshi, H. Shimokawa, Successful management of acute congestive heart failure by emergent caesarean section followed by adrenalectomy in a pregnant woman with cushing\u2019s syndrome-induced cardiomyopathy. Intern. Med. 58, 2819\u20132824 (2019). https:\/\/doi.org\/10.2169\/internalmedicine.2427-18","journal-title":"Intern. Med."},{"key":"3623_CR41","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/MAJ.0b013e3181a927e0","volume":"338","author":"M Peppa","year":"2009","unstructured":"M. Peppa, I. Ikonomidis, D. Hadjidakis, V. Pikounis, I. Paraskevaidis, T. Economopoulos, S.A. Raptis, D.T. Kremastinos, Dilated cardiomyopathy as the predominant feature of Cushing\u2019s syndrome. Am. J. Med. Sci. 338, 252\u2013253 (2009). https:\/\/doi.org\/10.1097\/MAJ.0b013e3181a927e0","journal-title":"Am. J. Med. Sci."},{"key":"3623_CR42","doi-asserted-by":"publisher","unstructured":"T. Sheikh, H. Shuja, S.R. Zaidi, A. Haque, Glucocorticoid-induced cardiomyopathy: Unexpected conclusion. BMJ Case Rep. 13, (2020). https:\/\/doi.org\/10.1136\/bcr-2020-237173","DOI":"10.1136\/bcr-2020-237173"},{"key":"3623_CR43","doi-asserted-by":"publisher","first-page":"e2011","DOI":"10.1097\/MD.0000000000002011","volume":"94","author":"L Marchand","year":"2015","unstructured":"L. Marchand, B. Segrestin, M. Lapoirie, V. Favrel, J. Dementhon, E. Jouanneau, G. Raverot, Dilated Cardiomyopathy Revealing Cushing Disease. A Case Report and Literature Review. Med. (U. S.) 94, e2011 (2015). https:\/\/doi.org\/10.1097\/MD.0000000000002011","journal-title":"Med. (U. S.)"},{"key":"3623_CR44","doi-asserted-by":"publisher","unstructured":"T.M. Hey, J.S. Dahl, T.H. Brix, E.V. S\u00f8ndergaard, D. Thomas, M. Hey, Biventricular hypertrophy and heart failure as initial presentation of Cushing\u2019s disease. BMJ Case Rep. (2013). https:\/\/doi.org\/10.1136\/bcr-2013","DOI":"10.1136\/bcr-2013"},{"key":"3623_CR45","doi-asserted-by":"publisher","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","volume":"141","author":"L Wei","year":"2004","unstructured":"L. Wei, T.M. Macdonald, B.R. Walker, Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease background: glucocorticoids have adverse systemic effects, in. Ann. Intern. Med. 141, 764\u2013770 (2004)","journal-title":"Ann. Intern. Med."},{"key":"3623_CR46","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1365-2265.2011.04124.x","volume":"75","author":"MJ Bolland","year":"2011","unstructured":"M.J. Bolland, I.M. Holdaway, J.E. Berkeley, S. Lim, W.J. Dransfield, J.V. Conaglen, M.S. Croxson, G.D. Gamble, P.J. Hunt, R.J. Toomath, Mortality and morbidity in Cushing\u2019s syndrome in New Zealand. Clin. Endocrinol. 75, 436\u2013442 (2011). https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04124.x","journal-title":"Clin. Endocrinol."},{"key":"3623_CR47","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/hrt.2003.020180","volume":"90","author":"PC Souverein","year":"2004","unstructured":"P.C. Souverein, A. Berard, T.P. Van Staa, C. Cooper, A.C.G. Egberts, H.G.M. Leufkens, B.R. Walker, Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart 90, 859\u2013865 (2004). https:\/\/doi.org\/10.1136\/hrt.2003.020180","journal-title":"Heart"},{"key":"3623_CR48","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1210\/jc.2012-3754","volume":"98","author":"NM Neary","year":"2013","unstructured":"N.M. Neary, O.J. Booker, B.S. Abel, J.R. Matta, N. Muldoon, N. Sinaii, R.I. Pettigrew, L.K. Nieman, A.M. Gharib, Hypercortisolism is associated with increased coronary arterial atherosclerosis: Analysis of noninvasive coronary angiography using multidetector computerized tomography. J. Clin. Endocrinol. Metab. 98, 2045\u20132052 (2013). https:\/\/doi.org\/10.1210\/jc.2012-3754","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3623_CR49","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1210\/jc.2012-3547","volume":"98","author":"MJ Barahona","year":"2013","unstructured":"M.J. Barahona, E. Resmini, D. Vilad\u00e9s, G. Pons-Llad\u00f3, R. Leta, T. Puig, S.M. Webb, Coronary artery disease detected by multislice computed tomography in patients after long-term cure of cushing\u2019s syndrome. J. Clin. Endocrinol. Metab. 98, 1093\u20131099 (2013). https:\/\/doi.org\/10.1210\/jc.2012-3547","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3623_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000318566","volume":"92","author":"M De Leo","year":"2010","unstructured":"M. De Leo, R. Pivonello, R.S. Auriemma, A. Cozzolino, P. Vitale, C. Simeoli, M.C. De Martino, G. Lombardi, A. Colao, Cardiovascular disease in Cushing\u2019s syndrome: Heart versus vasculature. Neuroendocrinology 92, 50\u201354 (2010). https:\/\/doi.org\/10.1159\/000318566","journal-title":"Neuroendocrinology"},{"key":"3623_CR51","doi-asserted-by":"publisher","unstructured":"C. Yano, M. Yokomoto-Umakoshi, M. Fujita, H. Umakoshi, S. Yano, N. Iwahashi, S. Katsuhara, H. Kaneko, M. Ogata, T. Fukumoto, E. Terada, Y. Matsuda, R. Sakamoto, Y. Ogawa, Coexistence of bone and vascular disturbances in patients with endogenous glucocorticoid excess. Bone Rep. 17, (2022). https:\/\/doi.org\/10.1016\/j.bonr.2022.101610","DOI":"10.1016\/j.bonr.2022.101610"},{"key":"3623_CR52","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1055\/s-0043-100385","volume":"49","author":"M Battocchio","year":"2017","unstructured":"M. Battocchio, A. Rebellato, A. Grillo, F. Dassie, P. Maffei, S. Bernardi, B. Fabris, R. Carretta, F. Fallo, Ambulatory arterial stiffness indexes in cushing\u2019s syndrome. Horm. Metab. Res. 49, 214\u2013220 (2017). https:\/\/doi.org\/10.1055\/s-0043-100385","journal-title":"Horm. Metab. Res."},{"key":"3623_CR53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1507\/endocrj.K09E-260","volume":"57","author":"I Akaza","year":"2010","unstructured":"I. Akaza, T. Yoshimoto, K. Tsuchiya, Y. Hirata, Endothelial dysfunction associated with hypercortisolism is reversible in cushing\u2019s syndrome. Endocr. J. 57, 245\u2013252 (2010)","journal-title":"Endocr. J."},{"key":"3623_CR54","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1530\/eje.0.1490549","volume":"149","author":"G Kirilov","year":"2003","unstructured":"G. Kirilov, A. Tomova, L. Dakovska, P. Kumanov, A. Shinkov, A.S. Alexandrov, Elevated plasma endothelin as an additional cardiovascular risk factor in patients with Cushing\u2019s syndrome. Eur. J. Endocrinol. 149, 549\u2013553 (2003)","journal-title":"Eur. J. Endocrinol."},{"key":"3623_CR55","doi-asserted-by":"publisher","first-page":"6616","DOI":"10.1210\/jc.2005-0656","volume":"90","author":"A Faggiano","year":"2005","unstructured":"A. Faggiano, D. Melis, R. Alfieri, M.C. De Martino, M. Filippella, F. Milone, G. Lombardi, A. Colao, R. Pivonello, Sulfur amino acids in Cushing\u2019s disease: Insight in homocysteine and taurine levels in patients with active and cured disease. J. Clin. Endocrinol. Metabol. 90, 6616\u20136622 (2005). https:\/\/doi.org\/10.1210\/jc.2005-0656","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"3623_CR56","doi-asserted-by":"publisher","unstructured":"G. Markousis\u2010Mavrogenis, F. Bacopoulou, C. Mavragani, P. Voulgari, G. Kolovou, G.D. Kitas, G.P. Chrousos, S.I. Mavrogeni, Coronary microvascular disease: The \u201cMeeting Point\u201d of Cardiology, Rheumatology and Endocrinology. Eur J Clin Invest. 52, (2022). https:\/\/doi.org\/10.1111\/eci.13737","DOI":"10.1111\/eci.13737"},{"key":"3623_CR57","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/01.CIR.0000141573.44737.5A","volume":"110","author":"RB Devereux","year":"2004","unstructured":"R.B. Devereux, B. Dahl\u00f6f, E. Gerdts, K. Boman, M.S. Nieminen, V. Papademetriou, J. Rokkedal, K.E. Harris, J.M. Edelman, K. Wachtell, Regression of hypertensive left ventricular hypertrophy by Losartan compared with atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 110, 1456\u20131462 (2004). https:\/\/doi.org\/10.1161\/01.CIR.0000141573.44737.5A","journal-title":"Circulation"},{"key":"3623_CR58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0002-9149(02)02381-0","volume":"90","author":"F Grothues","year":"2002","unstructured":"F. Grothues, G.C. Smith, J.C. Moon, M. BCh, N.G. Bellenger, P. Collins, H.U. Klein, D.J. Pennell, Comparison of Interstudy Reproducibility of Cardiovascular Magnetic Resonance With Two-Dimensional Echocardiography in Normal Subjects and in Patients With Heart Failure or Left Ventricular Hypertrophy. Am. J. Cardiol. 90, 29\u201334 (2002)","journal-title":"Am. J. Cardiol."},{"key":"3623_CR59","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4250\/jcu.2014.22.3.113","volume":"22","author":"JH Park","year":"2014","unstructured":"J.H. Park, K. Negishi, D.H. Kwon, Z.B. Popovic, R.A. Grimm, T.H. Marwick, Validation of global longitudinal strain and strain rate as reliable markers of right ventricular dysfunction: Comparison with cardiac magnetic resonance and outcome. J. Cardiovasc Ultrasound 22, 113\u2013120 (2014). https:\/\/doi.org\/10.4250\/jcu.2014.22.3.113","journal-title":"J. Cardiovasc Ultrasound"},{"key":"3623_CR60","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.echo.2014.07.006","volume":"27","author":"M Aurich","year":"2014","unstructured":"M. Aurich, F. Andr\u00e9, M. Keller, S. Greiner, A. Hess, S.J. Buss, H.A. Katus, D. Mereles, Assessment of left ventricular volumes with echocardiography and cardiac magnetic resonance imaging: Real-life evaluation of standard versus new semiautomatic methods. J. Am. Soc. Echocardiogr. 27, 1017\u20131024 (2014). https:\/\/doi.org\/10.1016\/j.echo.2014.07.006","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"3623_CR61","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.acvd.2011.04.003","volume":"104","author":"L Perdrix","year":"2011","unstructured":"L. Perdrix, N. Mansencal, B. Cocheteux, G. Chatellier, A. Bissery, B. Diebold, E. Mousseaux, E. Abergel, How to calculate left ventricular mass in routine practice? An echocardiographic versus cardiac magnetic resonance study. Arch. Cardiovasc Dis. 104, 343\u2013351 (2011). https:\/\/doi.org\/10.1016\/j.acvd.2011.04.003","journal-title":"Arch. Cardiovasc Dis."},{"key":"3623_CR62","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.amjcard.2005.01.065","volume":"95","author":"H Oe","year":"2005","unstructured":"H. Oe, T. Hozumi, K. Arai, Y. Matsumura, K. Negishi, K. Sugioka, K. Ujino, Y. Takemoto, Y. Inoue, J. Yoshikawa, Comparison of accurate measurement of left ventricular mass in patients with hypertrophied hearts by real-time three-dimensional echocardiography versus magnetic resonance imaging. Am. J. Cardiol. 95, 1263\u20131267 (2005). https:\/\/doi.org\/10.1016\/j.amjcard.2005.01.065","journal-title":"Am. J. Cardiol."},{"key":"3623_CR63","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.amjcard.2013.04.028","volume":"112","author":"K Kusunose","year":"2013","unstructured":"K. Kusunose, D.H. Kwon, H. Motoki, S.D. Flamm, T.H. Marwick, Comparison of three-dimensional echocardiographic findings to those of magnetic resonance imaging for determination of left ventricular mass in patients with ischemic and non-ischemic cardiomyopathy. Am. J. Cardiol. 112, 604\u2013611 (2013). https:\/\/doi.org\/10.1016\/j.amjcard.2013.04.028","journal-title":"Am. J. Cardiol."},{"key":"3623_CR64","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1161\/01.HYP.0000135249.66192.30","volume":"44","author":"K Alfakih","year":"2004","unstructured":"K. Alfakih, K. Walters, T. Jones, J. Ridgway, A.S. Hall, M. Sivananthan, New gender-specific partition values for ECG criteria of left ventricular hypertrophy: Recalibration against cardiac MRI. Hypertension 44, 175\u2013179 (2004). https:\/\/doi.org\/10.1161\/01.HYP.0000135249.66192.30","journal-title":"Hypertension"},{"key":"3623_CR65","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jcmg.2021.11.008","volume":"15","author":"K Moschetti","year":"2022","unstructured":"K. Moschetti, R.Y. Kwong, S.E. Petersen, M. Lombardi, J. Garot, D. Atar, F.E. Rademakers, L.M. Sierra-Galan, S. Mavrogeni, K. Li, J.L. Fernandes, S. Schneider, C. Pinget, Y. Ge, P. Antiochos, C. Deluigi, O. Bruder, H. Mahrholdt, J. Schwitter, Cost-Minimization Analysis for Cardiac Revascularization in 12 Health Care Systems Based on the EuroCMR\/SPINS Registries. JACC Cardiovasc Imaging 15, 607\u2013625 (2022). https:\/\/doi.org\/10.1016\/j.jcmg.2021.11.008","journal-title":"JACC Cardiovasc Imaging"},{"key":"3623_CR66","doi-asserted-by":"publisher","unstructured":"S.I. Mavrogeni, A. Kallifatidis, T. Kourtidou, N. Lama, A. Christidi, E. Detorakis, G. Chatzantonis, T. Vrachliotis, T. Karamitsos, K. Kouskouras, N. Kelekis. Cardiovascular Magnetic Resonance for evaluation of patients with cardiovascular disease. An overview of current indications, limitations and procedures. Hell. J. Cardiol. (2023). https:\/\/doi.org\/10.1016\/j.hjc.2023.01.003","DOI":"10.1016\/j.hjc.2023.01.003"},{"key":"3623_CR67","doi-asserted-by":"publisher","first-page":"e308","DOI":"10.1093\/ehjci\/jeac134","volume":"23","author":"S Mavrogeni","year":"2022","unstructured":"S. Mavrogeni, A. Pepe, R. Nijveldt, N. Ntusi, L.M. Sierra-Galan, K. Bratis, J. Wei, M. Mukherjee, G. Markousis-Mavrogenis, L. Gargani, L.E. Sade, N. Ajmone-Marsan, P. Seferovic, E. Donal, M. Nurmohamed, M.M. Cerinic, P. Sfikakis, G. Kitas, J. Schwitter, J.A.C. Lima, D. Dawson, M. Dweck, K.H. Haugaa, N. Keenan, J. Moon, I. Stankovic, E. Donal, B. Cosyns, Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging. Eur. Heart J. Cardiovasc Imaging 23, e308\u2013e322 (2022). https:\/\/doi.org\/10.1093\/ehjci\/jeac134","journal-title":"Eur. Heart J. Cardiovasc Imaging"},{"key":"3623_CR68","doi-asserted-by":"publisher","unstructured":"K. Ehrlich, C. Morbach, T. Reiter, P.U. Heuschmann, A. Hannemann, M. Fassnacht, S. St\u00f6rk, S. Hahner, T. Deutschbein, Rationale and design of the cardiovascular status in patients with endogenous cortisol excess study (CV-CORT-EX): a prospective non-interventional follow-up study. BMC Endocr Disord. 21, (2021). https:\/\/doi.org\/10.1186\/s12902-020-00665-7","DOI":"10.1186\/s12902-020-00665-7"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03623-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03623-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03623-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T21:17:16Z","timestamp":1709155036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03623-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":68,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["3623"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03623-0","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,21]]},"assertion":[{"value":"2 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}